Elemental Wellness News Today

/PRNewswire/ -- Rythmia Life Advancement Center, the leading life transformation center and recipient of over 2,300 five-star reviews on TripAdvisor, is...

/PRNewswire/ -- The Malibu Half Marathon, 5K & Kids Run presented by Rusnak BMW, is ready to set a new attendance record this year with over 4,500 registered...

By KAREN VELIE When San Luis Obispo picked the people who would operate three marijuana retail shops in the city, they selected Helios Dayspring and his

By KAREN VELIE After years of servility and deference, the City of San Luis Obispo turned on marijuana mogul Helios Dayspring, terminating his application

By KAREN VELIE After years of servility and deference, the City of San Luis Obispo turned on marijuana mogul Helios Dayspring, terminating his application

Cutting-edge life science company offers high upside cannabis medical product potential. The company aims to disrupt the drug development market by developing evidence-based cannabis products to help combat serious medical conditions

FREE Only logged in users are allowed to post comments. Register/ Log in The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site. (c) 2005-2021 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any ...

The Next Marijuana Boom Could Be Even Bigger Than The Last Published: January 18, 2021   That’s because, despite “Big Pharma’s” massive resources and staggering amounts of spending, no large pharmaceutical company has ever been able to solve the industry’s most critical problem.     Drug development for major pharmaceutical companies can take as long as a decade...and cost hundreds of billions of dollars in research and development.    Yet a small, little-known company – which...

Cutting-edge life science company offers high upside cannabis medical product potential